Last reviewed · How we verify
NCT03547050: REGAIN
Rolandic Epilepsy Genomewide Association International Study
trial testing Blood draw in Rolandic Epilepsy in 210 participants. Completed in 30 June 2023.
17 March 2023
Quick facts
| Lead sponsor | King's College London |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 210 |
| Start date | 1 June 2018 |
| Primary completion | 17 March 2023 |
| Estimated completion | 30 June 2023 |
| Sites | 13 locations across Italy, Greece, United Kingdom, Argentina, Canada, United States, Spain |
Drugs / interventions tested
- Blood draw — full drug profile →
- Existing samples
Conditions studied
- Rolandic Epilepsy — all drugs for Rolandic Epilepsy →
Sponsor
King's College London
Who can join
Adults 6 to 25, any sex, with Rolandic Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We have discovered a small change in the genetic code which increases the risk of the brainwave abnormality that is found in rolandic epilepsy. We now wish to confirm this using a second much larger sample of patients. We will investigate the other genetic changes that cause people with the brainwave abnormality to develop seizures, as well as problems with speech, coordination, attention and learning.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03547050
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood draw
Trials testing the same drug.
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
- NCT07252622 — Progesterone Levels and Frozen Embryo Transfer Outcomes · not yet recruiting
- NCT07382076 — Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population · active not recruiting
- NCT06011824 — A Study of Effect of Megakaryocytes and Platelets in Breast Cancer · completed
- NCT05912400 — Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1 · completed
Other recruiting trials for Rolandic Epilepsy
Currently open trials in the same condition.
- NCT04569708 — Sleep Spindles and Memory in Rolandic Epilepsy · NA · recruiting
Other King's College London trials
Trials by the same sponsor.
- NCT07357064 — Professional Decision Making in Childbirth. · not yet recruiting
- NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
- NCT07228962 — Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies · not yet recruiting
- NCT07365722 — Comparison of Two Non-surgical Procedure to Manage Gum Disease Around Implants. · NA · not yet recruiting
- NCT07378488 — Dance/Movement Therapy for Functional Neurological Disorder · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03547050 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King's College London
- Last refreshed: 6 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03547050.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing